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Objective: Because elongated mitral valve interstitial cells have features of myofi-
broblasts, it is likely that these cells are essential for the repair of injured valve
leaflets. We characterized the cellular morphology and pattern of repair of these
interstitial cells in wounds produced in vitro and tested the hypothesis that fibroblast
growth factor 2 enhances interstitial cell repair.
Methods: Mitral valve interstitial cells were plated onto glass coverslips, reached
confluence after 1 week, and were wounded by passage of a spatula along the center
of a monolayer, which created a linear wound with two edges. The wounds were
observed from 0 to 96 hours by phase-contrast microscopy. Wounds were also fixed
at 0, 2, and 24 hours and stained for fibroblast growth factor 2 and fibroblast growth
factor receptor 1 by means of immunofluorescence and laser confocal microscopy.
Results: Cells in confluent monolayers and in the monolayer behind the wound edge
formed a multilayered orthogonal pattern of elongated cells similar to fibroblasts.
Cells along the wound edge migrated into the wound after 4 hours, and at 24 hours
single cells with prominent lamellipodia and tails were present within the wound.
There was overlapping of cells as well, similar to smooth muscle cells. Fibroblast
growth factor 2 and fibroblast growth factor receptor 1 were present in the cells of
the undisturbed confluent monolayer. They were upwardly regulated relative to the
unwounded monolayer in the cells along the wound edge at 2 hours and in the
monolayer behind the wound edge at 24 hours. In single cells that migrated into the
wound, fibroblast growth factor 2 and fibroblast growth factor receptor 1 were
prominent. Fibroblast growth factor 2 showed a 6-fold increase in concentration
relative to unwounded cultures in conditioned medium from wounded cultures at 2
hours after wounding. Addition of a neutralizing antibody to fibroblast growth factor
2 significantly delayed wound closure at 24 to 96 hours. Addition of exogenous
fibroblast growth factor 2 to cultures at the time of wounding did not enhance wound
repair.
Conclusion: Mitral valve interstitial cells have the ability to repair wounds, and
fibroblast growth factor 2 is a modulator of these repair processes.
Heart valves consist of complex layers of histologically distincttissue that extend from the base of the valve toward the distal freeedge. Although much is understood about the anatomy of cardiacvalves,1-4 information about the cellular and molecular processesthat regulate valve leaflet structure and function remain poorlyunderstood.
Four types of cells are found in cardiac valve leaflets; valvular interstitial cells,
endocardial endothelial cells, cardiac muscle cells, and smooth muscle cells. The
surface of the leaflet is covered by endocardial endothelial cells, which extend as a
continuous layer from the endocardial endothelial cells of the atria and ventricles.5
Cardiac muscle extends into the base of mitral and tricuspid valves. Valves may
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have some vascularity, especially toward the base, and
smooth muscle cells are present in the walls of arterioles
and venules. Short bundles of smooth muscle cells are also
present. The most prevalent cell type in the valve is the
cardiac valve interstitial cell. These cells are found in all
layers of the valve and interact by means of gap and adhe-
rens junctions. In vivo, the valve interstitial cells have long
cytoplasmic extensions, prominent adhesion and gap junc-
tions, an incomplete basal lamina, and close association
with extracellular matrix.6 Some interstitial cells show
prominent microfilaments and intermediate filaments with
less prominent rough endoplasmic reticulum and Golgi ap-
paratus, whereas other cells show the opposite constella-
tion.6 Interstitial cells appear to represent a heterogeneous
population of cells with different phenotypic expressions.6-8
Some of the cells are thought to be of a myofibroblast
type,9,10 whereas others may secrete the valve matrix, in-
cluding collagen, elastin, and proteoglycans.6
Success in harvesting and culturing cardiac valve inter-
stitial cells in monolayer cell culture6 and in organ culture11
has allowed new knowledge to be acquired about the struc-
ture and function of these cells. Cultured valve interstitial
cells resemble fibroblasts morphologically, being elongated
and forming an orthogonal pattern of overgrowth after con-
fluence.6 The lack of a “hill and valley pattern” in postcon-
fluent cultures distinguishes these cultures from those of
vascular smooth muscle cells.12 Valvular interstitial cells
show other differences from mesenchymal type cells. We
have previously shown that there are differences between
interstitial cells and endothelial and smooth muscle cells
with respect to cell spreading and adhesion, two important
processes related to cell migration and repair.7 In addition,
Taylor and colleagues8 have shown that contractile func-
tions of valve interstitial cells have differences from those
of pericardial interstitial cells and skin fibroblasts.
The purpose of this study was to investigate the charac-
teristics of in vitro mitral valve interstitial cell (MVIC)
repair and the role of fibroblast growth factor 2 (FGF-2) in
regulating this repair. The rationale was that FGF-2 has
been shown to have a specific effect on the repair of vas-
cular endothelial and smooth muscle cells.13,14 We carried
out our experiments with an in vitro experimental wound
made in a confluent monolayer as a model of interstitial cell
repair.
Material and Methods
Mitral Valve Interstitial Cell Cultures
The anterior leaflet of the porcine mitral valve was used as a source
of interstitial cells.6 Explants were derived from the distal portion
of the valve, because occasional bundles of smooth muscle cells
were present toward the base and very small blood vessels were
most prominent toward the base. Briefly, the porcine heart was
opened, and the distal third of the anterior leaflet of the mitral
valve was rapidly removed and used for explant culture as previ-
ously described elsewhere.6 To remove endocardial cells, the atrial
and ventricular surfaces of the valve were scraped with a sterile
scalpel blade and rinsed in sterile phosphate-buffered saline solu-
tion. Pieces that measured 4  5 mm were cut from the tissue,
placed in 35 mm tissue culture dishes (Falcon; BD Biosciences,
San Jose, Calif), and grown in medium 199 (M-199), 10% fetal
bovine serum (FBS), and antibiotics in a humidified, 95% air and
5% carbon dioxide atmosphere in an incubator at 37°C. Cells
began to grow out of the explant after 3 to 5 days. After 3 weeks,
the cells that grew out of the explants were subcultured with 0.5 g
of trypsin (1:250) and 0.2 g/L of ethylenediaminetetraacetic acid in
Hanks’ buffered saline solution without calcium and magnesium
ion (trypsin-edetic acid; GIBCO BRL; Life Technologies, Inc,
Rockville, Md). The cells showed a growth pattern reminiscent of
fibroblasts, as previously described elsewhere.6 In all experiments
cell cultures of elongated cells were used from between 4 and 8
passages and grown in standard medium (M-199 and 5% FBS).
Wounding
A series of serum concentrations from 0% to 10% were used to
identify an optimum concentration, and 5% FBS was used for most
of the experiments. Three days after the cell cultures reached
confluence, a single 1.5-mm linear wound was made with a flat-
edged plastic cell scraper down the middle of the monolayer to
create a double-sided wound.13 The time of wounding was desig-
nated as 0 hours. Cultures to be used in wound closure measure-
ments were seeded in 6-well tissue culture plates. The plates were
marked with small scratches made with a sterile diamond-tip
pencil along the bottom exterior of each well and used as reference
points to measure closure. Each wounded culture was rinsed three
times with M-199 and then incubated with standard medium
(M-199 plus 5% FBS) with or without test agents. The extent of
wound closure was measured at given time points and expressed as
the extent of advancement of the cells into the wound at the
reference scratches relative to the original wound edge at time 0.
Experiments were carried out at least three times with three dishes
at each time point.
Wounded and unwounded cultures were photographed under
phase-contrast microscopy with a photomicroscope (Nikon Dia-
phot; Nikon Canada, Mississauga, Ontario) through an 10 eye-
piece and10 objective. Photomicrographs were taken at 2, 6, 24,
48, and 96 hours with Kodak 2415 film (ASA 125; Kodak Canada,
Toronto, Ontario) and developed with developer Kodak HC-110
(Kodak Canada) and printed on Kodabromide IIRC black and
white F3 glossy paper (Kodak Canada).
Localization of Fibroblast Growth Factor 2 and
Fibroblast Growth Factor Receptor 1
MVICs to be used in immunofluorescent studies were seeded on
22  22-mm sterile glass coverslips (Corning Incorporated, Corn-
ing, NY) in 35-mm tissue culture dishes (BD Bioscience, Oakville,
Ontario, Canada). Unwounded confluent monolayers and wounded
cultures were fixed and stained at various times after wounding to
localize FGF-2 and fibroblast growth factor receptor 1 (FGFR-1).
In addition, nuclei were localized with propidium iodide or SY-
TOX green staining (Molecular Probes, Inc, Eugene, Ore). Briefly,
cells on the coverslips were fixed with ice-cold ethanol and acetic
acid (95:5) for 4 minutes for FGF-2 localization or with 3%
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paraformaldehyde for 10 minutes for FGFR-1 localization. This
was followed by a 3.5-minute incubation with 0.1% Triton X-100
(The Dow Chemical Company, Midland, Mich) in phosphate-
buffered saline solution to make the cells permeable. After three
washes of 5 minutes each with phosphate-buffered saline solution,
the coverslips were incubated for 1 hour at room temperature with
a mouse monoclonal antibody against bovine brain basic FGF-2
(10 g/mL; Upstate Biotechnology, Lake Placid, NY) or incubated
overnight at 4°C with a rabbit antiserum against chicken FGFR-1
(1:100 dilution; Upstate Biotechnology). For negative control prepa-
Figure 1. Phase-contrast photomicrographs of porcine MVICs grown in 5% FBS (A, C, E, G) and 10% FBS (B, D, F,
H) along wound edge show patterns of migration of elongated cells at 2 (A, B), 4 (C, D), 24 (E, F), and 48 (G, H) hours
after wounding. All wounds were initially the same size. A, B, C, D, and F show cells along one edge; E, G, and
H show cells along both wound edges. Note cells with frontal lamellipodia and tail (C, D). Note single cells and
groups of cells present in wound early (E, F), and note contacts being made between cell processes later (G, H),
as wounds closed. Wounds in 10% FBS closed more rapidly. Bar indicates 100 m. Magnification 50.
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rations, nonimmune mouse immunoglobulin G and rabbit serum
(Jackson Immuno Research, West Grove, Pa) were used. Secondary
antibodies were goat antimouse Alexa 488 and goat antirabbit Alexa
568 immunoglobulin G (Molecular Probes). The coverslips were
washed three times with phosphate-buffered saline solution between
each of these steps. The stained coverslips were mounted with Fluoro
Guard (Bio-Rad Laboratories Inc, Hercules, Calif).
The cells were examined with a scanning confocal laser imag-
ing system (BioRad MRC 1024, BioRad, Toronto, Ontario, Can-
ada) fitted with an argon-krypton mixed-gas laser with excitation
wavelengths of 488, 568, and 647 nm. The system was connected
to a Nikon Optiphot microscope (Nikon Canada). Serial optical
sections were taken at 0.5-m intervals, and projections of the
optical sections were performed with the BioRad software. Color
photographs were taken from the digital images with Photo Shop
5.0 software (Adobe Systems Incorporated, San Jose, Calif). All
experiments were performed in triplicate.
Enzyme-Linked Immunosorbent Assay
FGF-2 concentration in culture medium at 2 hours after wounding
was measured by enzyme-linked immunosorbent assay in
wounded specimens and unwounded control specimens. We used
a multiwound model in which the cells were seeded in a 100-mm
tissue culture dish. Multiple wounds were made with a plastic
comblike device, resulting in 24 linear wounds each 1.5 mm in
width. Samples were assayed with the FGF-2 Quantikine immu-
noassay kit (R&D Systems, Minneapolis, Minn) according to
manufacturer instructions. Briefly, a blank, human recombinant
FGF-2 standards ranging from 5 to 640 pg/mL, and conditioned
medium samples (all in duplicate) were added to individual wells
of a 96-well plate previously coated with a monoclonal FGF-2
antibody. Samples were incubated for 2 hours, then incubated with
a horseradish peroxidase–conjugated polyclonal FGF-2 antibody
for 2 hours, and finally incubated with tetramethylbenzidine for 30
minutes, with intervening washes. The reaction was stopped with
a premixed solution containing 2N sulfuric acid and read spectro-
photometrically on a Titertek Multiscan Plus plate reader (Titertek
Instruments, Inc, Huntsville, Ala) at 450 nm, with correction at
550 nm. The concentration of FGF-2 was determined according to
the graded curve generated from FGF-2 standards.
Effects of Exogenous Fibroblast Growth Factor 2 and
its Antibody
Immediately after wounding, the cultures were rinsed with M-199
and incubated in standard medium (M-199 and 5% FBS) with or
without human recombinant FGF-2 (10 ng/mL; Upstate) or with or
without 10-g/mL neutralizing FGF-2 antibody (R & D Systems,
Minneapolis, MN). A control for neutralizing FGF-2 antibody was
antiacidic FGF-1 (R&D Systems) at 10 g/mL in medium (M-199
and 5% FBS), which had no effect on wound repair.
Statistical Analysis
The Student t test was performed to determine significant differ-
ences.
Results
Interstitial Cells at Wound Edge
The morphologic characteristics of the MVICs at the wound
edge were observed at 2, 4, 24, and 48 hours after wounding
(Figure 1). The elongated interstitial cells migrated outward
from the wound edge 4 hours after wounding, with few
contacts between cells. As the cells moved forward, many
moved into the wound as single cells displaying a prominent
frontal lamellipodia and a thin tail. Initially the frontal
lamellipodia was directed at right angles to the wound edge
in cells within the wound edge; however, once the cells
were out into the wound edge, some had the frontal lamel-
lipodia directed toward the monolayer or parallel to the
wound edge. This suggests that once within the wound,
MVICs were migrating independently of wound location or
other cells in the wound. This surmise is supported by the
finding that single cells did overlap each other well before
the monolayer was reestablished as a confluent monolayer.
Serum Effect on Wound Repair
The extent of MVIC wound repair was dependent on serum
concentration when measured at 24 hours after wounding
(Figure 2).
Localization of Fibroblast Growth Factor 2 and
Fibroblast Growth Factor Receptor 1
There was punctate immunolocalization of FGF-2 and FGFR-1 in
undisturbed confluent monolayers and in the monolayer away
Figure 2. Wounded cultures of porcine MVICs showing extent of
wound closure at 24 hours in cultures incubated with standard
M-199 and varying concentrations of FBS. Error bars represent
SD.
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from the wound edge in wounded cultures (Figures 3 and 4).
Both FGF-2 and FGFR-1 were distributed throughout the cell
cytoplasm, with some nuclear staining. At 2, 24, 48, and 72
hours, cells at the wound edge and out in the wound showed
enhanced staining for FGF-2 and FGFR-1, and FGFR-1 stain-
ing was prominent in the cell nucleus (Figures 3 and 4).
Effect of Exogenous Fibroblast Growth Factor 2 and
its Antibody
Incubation of wounded cultures with FGF-2 neutralizing
antibody was associated with decreases in repair at 48, 72,
and 96 hours (Figure 5). Cultures incubated with anti-
FGF-1 did not show any difference in wound repair from
untreated control cultures. Exogenous FGF-2 at 10 ng/mL
did not show any enhanced repair (data not shown). The
concentrations of FGF-2 in conditioned medium from cul-
tures at 2 hours after wounding were 99  20 pg/mL in
wounded cultures and 14 6 pg/mL in unwounded cultures
(P  .015).
Discussion
We are the first to report on the in vitro characteristics of
MVICs. This in vitro model, a denuding wound made in a
confluent monolayer, has been useful in characterizing en-
dothelial,13 epithelial,15 and smooth muscle cell12 wound
repair and in studying the regulation of repair. We found
that the pattern of repair exhibited by MVICs was similar to
that of smooth muscle cells12 and fibroblasts. The morpho-
logic characteristics of the MVICs at the wound edge and in
the wound were similar to those of smooth muscle cells and
fibroblasts.12 The extent of MVIC repair was dependent on
serum concentration and to some extent on the FGF-2 and
its receptor, FGFR-1.
The MVICs repaired the wound in a fashion similar to
that of smooth muscle cells12 and fibroblasts.16 The cells
migrated free from the wound edge, and many cells mi-
grated singly into the wound. Once out of the monolayer,
the cells migrated in all directions, as indicated by the
position of the frontal lamellipodia and the thin tail. Similar
to smooth muscle cells, the MVIC overlapped each other
well before confluence. We did not explore the role of
matrix in regulating repair; however, this is likely to be
important, because in vivo the interstitial cells are present in
a 3-dimensional matrix within the valve leaflet. Likely ma-
trix molecules that should be considered initially include
Figure 3. Immunofluorescent photomicrographs of interstitial cells 24 hours after wounding stained for FGF-2. Cell
nuclei are stained with propidium iodide. A, Within wound; B, at wound edge; C, within monolayer in unwounded
area; D, in unwounded monolayer. Bar indicates 50 m. Magnification 600.
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collagens I, III, and VIII,17 osteopontin,18 and the metallo-
proteinases,19 a family of enzymes that degrade matrix and
facilitate cell migration. In addition, the transformation of
endocardial cardiac cushion cells to mesenchymal cells in
the embryo is characterized by migration of the cells into
and through the matrix of the cardiac cushion to become the
future interstitial cells of the valve.20
We found that FGF-2, a member of a large family of
polypeptides that play roles in cell growth and differentia-
tion and in wound healing,21 and its receptor FGFR-1,22 a
high-affinity transmembrane tyrosine kinase receptor, were
upwardly regulated in MVICs within the wound, in cells at
the wound edge, and in cells just behind the edge. Cells well
away from the wound edge and in unwounded monolayers
showed less staining. The conditioned medium of the
wounded monolayer did show a 6-fold increase in FGF-2
after wounding, which explains in part why neutralizing
antibodies to FGF-2 reduce the rate of wound closure.
FGF-2 and FGFR-1 have been shown to enhance vascular
cell migration and repair of both endothelial cells13 and
smooth muscle cells.23 Our findings are thus important from
a therapeutic viewpoint, because FGF-2 also appears to
promote valve repair and thus any vascular therapies with
FGF-2 would not adversely affect valve repair. The mech-
anisms of action of FGF-2 have not been identified, al-
though we have shown that FGF-2 promotes both an actin
cytoskeleton orientation that favors migration14 and an ori-
entation of centrosomes and microtubules that enhances
directed cell migration.13 We have not explored the mito-
genic effect of FGF-2 on the proliferative component of
MVIC wound repair.24 Because FGF-2 is known to be
mitogenic,25 it is likely that there is a mitogenic effect in
addition to the effect on cell migration. The finding that
FGFR-1 is expressed in the nuclei of cells involved in repair
is consistent with a recent report that FGFR-1 translocates
to the nucleus and nuclear FGFR-1 induces C-Jun and is
involved in the regulation of cell proliferation.26
Our previous studies11 and those of others27,28 have
shown that MVICs repair wounds in valve organ culture
systems. Recent studies have shown that interstitial cells
repair sheep valves in vivo.29 In our current studies, we were
able to use the simple in vitro experimental wound model
system to begin to understand the regulation of repair. An
understanding of the regulation of the interstitial cell repair
Figure 4. Immunofluorescent photomicrographs of interstitial cells stained for FGFR-1 at 24 hours after wounding.
Cell nuclei are stained with SYTOX Green. A, Cells at wound edge; B, cells behind wound edge; C, cells within
monolayer away from wound edge. Bar indicates 30 m. Magnification 600.
Figure 5. Experimental in vitro wounds of elongated MVICs incu-
bated with (black bars) and without (hatched bars) antibody to
FGF-2. Error bars represent SD. P .20, .045, and .002 at 24, 48, and
72 hours.
Surgery for Acquired Cardiovascular Disease Gotlieb, Rosenthal, Kazemian
596 The Journal of Thoracic and Cardiovascular Surgery ● September 2002
A
CD
processes will enhance our ability to optimize surgical pro-
cedures that require repair of valve leaflets,30,31 to design
better prosthetic valves,32 and to develop strategies for
successful cardiovascular tissue engineering.33
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